New Blood Test Based on Gut Health for Early Dementia Prediction

A small, cross-sectional study explored whether gut microbiome–related metabolites detectable in blood could help distinguish adults with early cognitive changes from healthy controls. The investigators analyzed paired blood and stool samples from 150 adults aged 50 and over, including individuals with no cognitive impairment, mild cognitive impairment (MCI), or subjective cognitive impairment (SCI).

They identified 33 gut microbiome–associated molecules and microbe-derived metabolites and evaluated combinations using AI-driven machine learning. Six metabolites were sufficient for classification, achieving about 79% accuracy in separating the three groups and over 80% accuracy in distinguishing healthy individuals from those with MCI.

The results support the concept that the gut–brain axis may reflect early cognitive decline and that blood-based metabolite profiling coupled with microbiome analysis could offer a less invasive approach to early detection. Uncertainty remains regarding the generalizability and predictive value for progression to dementia, given the study’s cross-sectional design and modest size.

The authors suggest that future work could explore diet, probiotics, and microbiome-targeted therapies as potential prevention strategies, contingent on further validation.